![]() |
市场调查报告书
商品编码
1872749
冷雷射治疗市场规模及预测(2021-2031年),全球及区域份额、趋势及成长机会分析报告涵盖范围:按产品、应用、最终用户划分Cold Laser Therapy Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User |
||||||
2024年冷雷射治疗市场规模为3.5633亿美元,到2031年将达到5.6262亿美元;预计2025-2031年期间的复合年增长率将达到6.90%。
推动市场成长的关键因素包括慢性疼痛疾病(例如骨科疾病)的日益普遍,以及冷雷射在皮肤科的应用,这些因素共同促进了冷雷射疗法市场的成长。然而,高昂的治疗费用阻碍了市场的成长。
冷激光治疗市场的市场驱动因素
冷雷射疗法在多个医疗领域有广泛的应用,涵盖疼痛管理、骨科、皮肤科和牙科等。由于关节炎、肌肉骨骼损伤、神经性疼痛和慢性损伤等骨科疾病的盛行率不断上升,医疗机构和家庭护理中冷雷射疗法的应用也日益增加。世界卫生组织(WHO)发布的资料显示,截至2021年2月,全球约有17.1亿人患有肌肉骨骼疾病,其中腰痛是最常见的肌肉骨骼疾病,影响全球5.68亿人。冷雷射疗法是一种非侵入性且有效的治疗方法,可以缓解慢性下背痛。 Hindawi于2022年2月发表了一项题为「低强度雷射疗法治疗椎间盘源性腰椎神经根病变患者的疗效」的研究,该研究纳入了110名患有急性腰痛和单侧椎间盘源性腰椎神经根病变的患者。在所有患者中,55例接受了低强度雷射疗法(LLLT)合併常规物理治疗,另55例患者作为对照组,仅接受了常规物理治疗。研究表明,在治疗椎间盘源性腰椎神经根病变方面,与单独使用常规物理治疗相比,LLLT作为常规物理治疗的辅助疗法,能够显着改善局部躯干活动度、疼痛强度及相关功能障碍。
此外,冷雷射疗法在皮肤科和美容医学领域被广泛用于非侵入性皮肤再生、抗衰老治疗和改善肤质。低强度雷射疗法(LLLT)最成功的商业应用是治疗男性和女性的雄性秃(AGA)。 Springer Link 于 2022 年 2 月发表了一项题为「低强度雷射疗法治疗雄性秃的疗效评估」的研究,该研究使用了经美国食品药物管理局(FDA)批准的 iHelmet(深圳思力科技有限公司)治疗 1383 名患者。研究表明,LLLT 头盔治疗对 51.9% 的轻度 AGA 患者和 57.4% 的中重度 AGA 患者俱有中等程度的疗效。因此,上述因素促使冷雷射设备作为一种治疗手段在现代医疗保健领域中越来越广泛的应用,并推动了冷雷射疗法市场的成长。
冷雷射治疗市场:细分市场概览
依产品划分,冷雷射治疗市场分为仪器和配件两大类。 2024年,仪器类产品占据了冷雷射治疗市场更大的份额,预计在2024年至2031年期间将维持较高的复合年增长率。
依应用领域划分,冷雷射治疗市场可分为骨科、皮肤科、神经科和其他领域。预计到2024年,骨科领域将占据最大的市场。
依最终用户划分,市场可分为医院、专科诊所、家庭护理机构和其他机构。 2022年,医院占据了最大的市场。预计在2024年至2031年期间,专科诊所的复合年增长率将最高。专科诊所通常专注于某些特定疾病,例如疼痛治疗、运动伤害、物理治疗、皮肤科或牙科,而这些领域正是冷雷射疗法的重要应用领域。这种方法使诊所能够利用冷雷射设备提供更好的治疗效果并累积更丰富的专业知识,从而提高患者的满意度和信任度。在专科诊所中,冷雷射疗法通常与物理治疗、脊椎矫正、针灸或皮肤护理疗程相结合。除了提高治疗效果外,这种互补策略也有助于诊所区别于一般医院。
冷雷射治疗市场:地域概览
根据地理位置,市场可分为北美、亚太、欧洲、中东和非洲以及南美和中美洲。就收入而言,北美在2024年占据冷雷射治疗市场的主导地位。预计亚太地区在预测期内将实现冷雷射治疗市场最快的复合年增长率。
2022年,北美占据全球最大的市场份额,预计从2022年到2030年将继续保持领先地位。 2022年,美国在北美地区市占率最大,其次是加拿大。根据美国疾病预防与健康促进办公室预测,由于人口老化和肥胖等其他人口趋势,到2040年,关节炎患者人数预计将上升至7,840万人。美国骨科疾病和肌肉骨骼损伤的盛行率很高,这扩大了该地区冷雷射疗法的市场份额。根据《加拿大健康科技杂誌》报道,2022年,加拿大约有800万人患有慢性疼痛,80%的成年人一生中至少经历过一次慢性下背痛。这些人每天都面临着影响其社交、身体、心理和职业等方面的各种挑战。 2024-2031 年间,Erchonia FX 635 等创新冷雷射设备的普及、完善的医疗保健基础设施以及先进雷射治疗技术的日益普及,预计将推动区域市场成长。
The cold laser therapy market size was valued at US$ 356.33 million in 2024 to US$ 562.62 million by 2031; it is anticipated to record a CAGR of 6.90% during 2025-2031.
Key factor driving the market growth are the growing prevalence of chronic pain conditions such as orthopedic disorders and utilization of cold laser in dermatology propel the cold laser therapy market growth. However, high treatment costs hamper the growth of the market.
Market Drivers of the Cold Laser Therapy Market
Cold laser therapy has diverse applications across multiple healthcare domains, spanning pain management, orthopedics, dermatology, and dentistry. Due to the rising prevalence of orthopedic conditions such as arthritis, musculoskeletal injuries, neuropathic pain, and chronic injuries, the utilization of cold laser therapy in healthcare institutions and homecare settings has increased. According to the data published by the World Health Organization (WHO), in February 2021, ~1.71 billion individuals worldwide suffered from musculoskeletal problems, with lower back pain being the most widespread musculoskeletal condition, affecting 568 million people globally. Cold laser therapy is a noninvasive and effective treatment to alleviate chronic back pain. A study, "Effectiveness of Low-Level Laser Therapy in Patients with Discogenic Lumbar Radiculopathy," published by Hindawi in February 2022, was carried out with 110 patients suffering from acute lower back pain and unilateral discogenic lumbar radiculopathy. Of the total patients, 55 patients were treated with LLLT combined with conventional physical therapy, while the other control group of 55 patients was treated with only conventional physical therapy. The study demonstrated that LLLT, as an adjunct therapy to conventional physical therapy, significantly improved local trunk movements, pain intensity, and related functional disability, as compared with conventional physical therapy alone in the treatment of discogenic lumbar radiculopathy.
Additionally, cold laser therapy is employed in dermatology and aesthetic medicine for noninvasive skin rejuvenation, anti-aging treatment, and improvement of skin texture. The most successful commercial use of LLLT is in managing androgenetic alopecia (AGA) for both men and women. A study, "Efficacy Assessment for Low-Level Laser Therapy in the Treatment of Androgenetic Alopecia," published by Springer Link in February 2022, was carried out on 1,383 patients using Food and Drug Administration (FDA)-cleared iHelmet (Slinph Technologies Co., Ltd, Shenzhen, China). The study showed that treatment with LLLT helmets was moderately effective for 51.9% of users with mild AGA and 57.4% with moderate-to-severe AGA. Therefore, the abovementioned factors contribute to the growing utilization of cold laser devices as a therapeutic modality in modern healthcare settings and are responsible for the cold laser therapy market growth.
Cold Laser Therapy Market: Segmental Overview
The cold laser therapy market, by product, is segmented into instruments and accessories. The instruments segment held the larger cold laser therapy market share in 2024 and is anticipated to register the higher CAGR during 2024-2031.
The cold laser therapy market, by application, is segmented into orthopedics, dermatology, neurology and others. The orthopedics segment is expected to hold the largest market share in 2024.
The market, by end user, is segmented into hospitals, specialty clinics, homecare settings, and others. In 2022, the hospital segment held the largest share of the market The specialty clinics segment is anticipated to register the highest CAGR during 2024-2031. Specialty clinics frequently concentrate on certain ailments, such as pain treatment, sports injuries, physiotherapy, dermatology, or dentistry, all of which are important fields in which cold laser therapy finds use. This approach increases patient happiness and trust by enabling clinics to use cold laser equipment to provide better results and develop deeper expertise. Cold laser therapy is frequently combined with physiotherapy, chiropractic adjustments, acupuncture, or skincare procedures in specialty clinics. In addition to improving therapeutic effectiveness, this complementary strategy aids clinics in setting themselves apart from regular hospitals.
Cold Laser Therapy Market: Geographical Overview
Based on geography, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, North America dominated the cold laser therapy market share in 2024. Asia Pacific is expected to register the fastest CAGR in the cold laser therapy market during the forecast period.
In 2022, North America held the largest global market share and is estimated to continue its dominance from 2022 to 2030. The US held the largest market share in the region in 2022, followed by Canada. According to by US Office of Disease Prevention and Health Promotion, the prevalence of arthritis is expected to rise to 78.4 million by 2040 due to aging and other population trends such as obesity. The US has a high prevalence of orthopedic diseases and musculoskeletal injuries, which expand the cold laser therapy market share in the region. According to the Canadian Journal of Health Technologies, in 2022, ~8 million people in Canada live with chronic pain and 80% of adults experience chronic low back pain at least once during their lifetime. These individuals face various challenges impacting their social, physical, mental, and professional aspects on a daily basis. The availability of innovative cold laser devices such as Erchonia FX 635, well-developed healthcare infrastructure, and the rising adoption of advanced laser therapy technologies are expected to fuel the regional market growth during 2024-2031.